3 Result(s)
-
Article
Open AccessRisk of pneumocystosis after early discontinuation of prophylaxis among HIV-infected patients receiving highly active antiretroviral therapy
Risk of pneumocystosis after discontinuation of primary or secondary prophylaxis among HIV-infected patients before CD4 counts increase to ≧200 cells/μL (early discontinuation) after receiving highly active an...
-
Article
Open AccessImpact of first-line protease inhibitors on predicted resistance to tipranavir in HIV-1-infected patients with virological failure
Tipranavir (TPV) is a recently approved nonpeptidic protease inhibitor (PI) of HIV-1 and has been indicated for those infected with PIs-resistant HIV-1. However, in clinical practice, whether the HIV-1 from th...
-
Article
Open AccessAssociation between amebic liver abscess and Human Immunodeficiency Virus infection in Taiwanese subjects
Invasive amebiasis is an emerging parasitic disorder in Taiwan, especially in patients diagnosed with human immunodeficiency virus (HIV) infection. Thirty-three Taiwanese subjects with amebic liver abscess (AL...
